Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy

CardioRenal Medicine - Switzerland
doi 10.1159/000342968
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG